Form 4 holding
President, CEO, and Chairman, Director
Atea Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 5,866,025
- Estimated value
- $20,941,709
- Report date
- 31 Jan 2026
- Price
- $3.57
- Ownership
- Held by JPM Partners LLC